StreetAlpha.app
Home › Stocks › AZR

Azora Therapeutics, Inc. (DE) (AZR)

$3.76
▼ −1.31%
LAST CLOSE · NOV 17

Azora Therapeutics develops AD04, an investigational treatment for alcohol use disorder and other addiction and related disorders. It last closed at $3.76 on Nov 17, down 1.31% on the day.

AI Auto Pilots
Is AZR in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Net income
−$120.6M
EPS (diluted)
−$17.99
Valuation
Market cap
$53.7M
14.3M shares
P/E
–
No P/E while losing money
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$22.0M
At Sep 30
Shareholder equity
−$21.1M
Shares outstanding
14.3M
At Nov 9
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: −$19.4M−$19.4MFY2021FY2022: −$12.7M−$12.7MFY2022FY2023: −$5.1M−$5.1MFY2023FY2024: −$13.2M−$13.2MFY2024FY2025: −$8.0M−$8.0MFY2025

From AZR's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 12). Last 12 months adds up the four latest quarters.

Last report
Nov 12
2026 · next date not on the calendar yet
Consensus EPS forecast
—
 
Year-ago EPS
—
Not on file
Options-implied move
—
 
Analyst consensus
1 Buy
1 firm · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
1 Buy
1firm
1 Buy0 Hold0 Sell
Only 1 firm rated AZR in the past 90 days, not enough for a consensus
Average 12-month target
$14.00
▲ 272.3% upside

Based on 1 analyst who set a price target on AZR in the past 90 days. The average target is $14.00, with a high of $14.00 and a low of $14.00, compared with the last close of $3.76.

Low $14.00Avg $14.00High $14.00
Blue marker: last close $3.76
Highest target$14.00
Average target$14.00
Lowest target$14.00
Latest rating changes
Jones TradingInitiated
Nov 2Buy$14
DateFirmActionRatingPrice target
Nov 2Jones TradingInitiatedBuy$14
Loading…

Whale Options Flow

90D

No whale options trades in AZR in the last 90 days.

Loading…

See today’s whale options flow across the market →

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether AZR is in one of them and how their past AZR trades turned out.

AZR in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered AZR in an article yet. Here's the latest on the wider market.

About Azora Therapeutics, Inc. (DE)

Azora Therapeutics is a clinical stage biopharmaceutical company that develops treatments for addiction and related disorders. Its lead candidate, AD04, is being developed for alcohol use disorder in patients with certain genetic profiles, identified using a companion genetic test. The company's main focus is completing clinical development for AD04 to meet regulatory requirements in the United States and Europe. It has no products approved for sale yet and is based in Encino, California.

Headquarters
Encino, CA